Matches in SemOpenAlex for { <https://semopenalex.org/work/W1992232011> ?p ?o ?g. }
Showing items 1 to 60 of
60
with 100 items per page.
- W1992232011 endingPage "A67" @default.
- W1992232011 startingPage "A67" @default.
- W1992232011 abstract "Podophyllotoxin is a natural product obtained from endangered Berberidaceae family species. Derivatives namely etoposide, etopophos and teniposide have been developed from podophyllotoxin and are currently used in clinic for the treatment of a variety of malignancies since five decades. Synthesis of podophyllotoxin is not feasible so far and due to this reason structural modification of podophyllotoxin could not be explored very well. The structural complexity of podophyllotoxin, arising from the presence of four stereogenic carbons in ring C has restricted most of the structural activity relationship (SAR) studied by derivatization of the parent natural product rather than by de novo multi-step chemical synthesis. In past we have developed synthetic analogues of podophyllotoxin i.e. aza-podophyllotoxin derivatives an important scaffold to address this chemistry. We have developed some heterocyclic analogues of podophyllotoxin i.e. N-hydroxyethyl-4-aza-podophyllotoxin derivatives. Owing to their promising activity against 60 cell lines at NCI, we further developed a novel library of N-hydroxyethyl-4-aza-didehyropodophyllotoxin derivatives substituted at ring-E by halogens. This was followed by a screen of in-vivo activity using a panel of tumor hollow-grafts implanted in mice consisting of breast (MDA-MB-231), non-small lung (NCI-H23 and NCI-H522), colon (SW-620 and COLO 205), melanoma (UACC-62, MDA-MB-435 and LOXIMVI), ovarian (OVCAR-5 and OVCAR-3) and CNS (U251 and SF-295) cell lines. These new compounds shows comparatively good activity against ovarian and melanoma cancer lines. Citation Format: Ajay Kumar, Vineet Kumar, Antonio E. Alegria, Malhotra V. Sanjay. Syntheses and antitumor activities on NCI-60 human tumor cell line protocol of novel N-hydroxyethyl-4-aza-didehyropodophyllotoxin derivatives with halo substitutions on ring-E. [abstract]. In: Proceedings of the Eleventh Annual AACR International Conference on Frontiers in Cancer Prevention Research; 2012 Oct 16-19; Anaheim, CA. Philadelphia (PA): AACR; Cancer Prev Res 2012;5(11 Suppl):Abstract nr A67." @default.
- W1992232011 created "2016-06-24" @default.
- W1992232011 creator A5000386663 @default.
- W1992232011 creator A5002143120 @default.
- W1992232011 creator A5055441982 @default.
- W1992232011 creator A5057889514 @default.
- W1992232011 date "2012-11-01" @default.
- W1992232011 modified "2023-09-27" @default.
- W1992232011 title "Abstract A67: Syntheses and antitumor activities on NCI-60 human tumor cell line protocol of novel N-hydroxyethyl-4-aza-didehyropodophyllotoxin derivatives with halo substitutions on ring-E" @default.
- W1992232011 doi "https://doi.org/10.1158/1940-6207.prev-12-a67" @default.
- W1992232011 hasPublicationYear "2012" @default.
- W1992232011 type Work @default.
- W1992232011 sameAs 1992232011 @default.
- W1992232011 citedByCount "0" @default.
- W1992232011 crossrefType "journal-article" @default.
- W1992232011 hasAuthorship W1992232011A5000386663 @default.
- W1992232011 hasAuthorship W1992232011A5002143120 @default.
- W1992232011 hasAuthorship W1992232011A5055441982 @default.
- W1992232011 hasAuthorship W1992232011A5057889514 @default.
- W1992232011 hasConcept C178790620 @default.
- W1992232011 hasConcept C185592680 @default.
- W1992232011 hasConcept C2780378348 @default.
- W1992232011 hasConcept C502942594 @default.
- W1992232011 hasConcept C54355233 @default.
- W1992232011 hasConcept C71240020 @default.
- W1992232011 hasConcept C71924100 @default.
- W1992232011 hasConcept C81885089 @default.
- W1992232011 hasConcept C86803240 @default.
- W1992232011 hasConcept C98274493 @default.
- W1992232011 hasConceptScore W1992232011C178790620 @default.
- W1992232011 hasConceptScore W1992232011C185592680 @default.
- W1992232011 hasConceptScore W1992232011C2780378348 @default.
- W1992232011 hasConceptScore W1992232011C502942594 @default.
- W1992232011 hasConceptScore W1992232011C54355233 @default.
- W1992232011 hasConceptScore W1992232011C71240020 @default.
- W1992232011 hasConceptScore W1992232011C71924100 @default.
- W1992232011 hasConceptScore W1992232011C81885089 @default.
- W1992232011 hasConceptScore W1992232011C86803240 @default.
- W1992232011 hasConceptScore W1992232011C98274493 @default.
- W1992232011 hasIssue "11 Supplement" @default.
- W1992232011 hasLocation W19922320111 @default.
- W1992232011 hasOpenAccess W1992232011 @default.
- W1992232011 hasPrimaryLocation W19922320111 @default.
- W1992232011 hasRelatedWork W2011746025 @default.
- W1992232011 hasRelatedWork W2162041534 @default.
- W1992232011 hasRelatedWork W2274080215 @default.
- W1992232011 hasRelatedWork W2328656573 @default.
- W1992232011 hasRelatedWork W2331581887 @default.
- W1992232011 hasRelatedWork W2748952813 @default.
- W1992232011 hasRelatedWork W2899084033 @default.
- W1992232011 hasRelatedWork W2935889742 @default.
- W1992232011 hasRelatedWork W2950680569 @default.
- W1992232011 hasRelatedWork W2951777384 @default.
- W1992232011 hasVolume "5" @default.
- W1992232011 isParatext "false" @default.
- W1992232011 isRetracted "false" @default.
- W1992232011 magId "1992232011" @default.
- W1992232011 workType "article" @default.